Agenus Inc. (AGEN) vs Surrozen, Inc. (SRZN)
- Agenus Inc. AGEN 6.04 −9.58%
- Surrozen, Inc. SRZN 23.44 −6.50%
Agenus Inc. and Surrozen, Inc. are both Biotechnology companies. Agenus Inc. and Surrozen, Inc. are of similar size ($301.7M and $294.7M). Surrozen, Inc. has negative trailing earnings, so its P/E is not meaningful; Agenus Inc. trades at 2.3×. Agenus Inc. grew revenue faster over the last twelve months: 30.5% against −8.79%. Agenus Inc. has the higher net margin (69.2% vs −2,887.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Agenus Inc. leads on 11 and Surrozen, Inc. on 4.
Valuation
Profitability
| Metric | AGEN | SRZN | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.52% | 100.00% | 65.16% |
| Operating margin | 27.28% | (385.28%) | 0.00% |
| Net margin | 69.18% | (2,887.07%) | 0.00% |
| Free cash flow margin | (73.97%) | (303.92%) | 0.00% |
| Return on equity | (33.86%) | 387.44% | (56.36%) |
| Return on assets | 51.30% | (304.47%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack